Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

BACKGROUND: Biomarkers that can be used to accurately assess the residual risk of disease recurrence in women with hormone receptor–positive breast cancer are clinically valuable. We evaluated the prognostic value of the Breast Cancer Index (BCI), a continuous risk index based on a combination of HO...

Descripción completa

Detalles Bibliográficos
Autores principales: Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700696/
https://www.ncbi.nlm.nih.gov/pubmed/26728744
http://dx.doi.org/10.1186/s13058-015-0660-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700696/
https://www.ncbi.nlm.nih.gov/pubmed/26728744
http://dx.doi.org/10.1186/s13058-015-0660-6

Ejemplares similares